ALDH1A1 and non-small cell lung carcinoma: Based on the above findings, it is now known that treatment of cisplatin-resistant NSCLC sublines with ATRA and retinol significantly inhibits ALDH1 activity and reduces the ALDH1+ve CSC subpopulation.